Pulse Biosciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $13.7M | $3.6M |
| FY2016 | — | $25.3M | $2.1M |
| FY2017 | — | $46.0M | $3.4M |
| FY2018 | — | $66.3M | $51.1M |
| FY2019 | — | $30.7M | $6.9M |
| FY2020 | — | $22.9M | $12.5M |
| FY2021 | — | $35.7M | $28.6M |
| FY2022 | — | $-2.2M | $61.1M |
| FY2023 | — | $44.4M | $44.4M |
| FY2024 | — | $114.9M | $118.0M |